Cystic Fibrosis Clinical Trials in New York, New York

5 studies are recruiting for cystic fibrosis in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

   This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children with cystic fibrosis (CF).

   Stage

   Not phased

   Ages

   Up to 10

   Site

   Children's Hospital of New York, New York, New York

   Locations

   35 in total

   Run by

   Sonya Heltshe

   See if you can join NCT04509050 on ClinicalTrials.gov

2. Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

   The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of respiratory symptoms in people with CF that needs me…

   Stage

   Phase 4

   Ages

   6 and older

   Site

   Lenox Hill Hospital Cystic Fibrosis Center, New York, New York

   Locations

   60 in total

   Run by

   Chris Goss

   See if you can join NCT05548283 on ClinicalTrials.gov

3. A Study Assessing KB407 for the Treatment of Cystic Fibrosis

   This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Northwell Health Physicians, New York, New York

   Locations

   6 in total

   Run by

   Krystal Biotech, Inc.

   See if you can join NCT05504837 on ClinicalTrials.gov

4. A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

   The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to in…

   Stage

   Not phased

   Ages

   12 and older

   Site

   Columbia University Cystic Fibrosis Program, New York, New York

   Locations

   68 in total

   Run by

   Nicole Hamblett

   See if you can join NCT06504589 on ClinicalTrials.gov

5. A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

   This is a Phase 1/2 multicenter, open-label, single dose trial of SP-101 investigational gene therapy in adults with CF who are ineligible for or intolerant to CFTR modulator therapy.

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Columbia University, New York, New York

   Locations

   4 in total

   Run by

   Spirovant Sciences, Inc.

   See if you can join NCT06526923 on ClinicalTrials.gov